Depression :: Antidepressant and Helicon, halicon
Helicon Therapeutics, Inc. is a pioneer in the development of therapies for memory-related diseases such as Alzheimer’s and Parkinson’s diseases. Helicon, based in Farmingdale, New York, was originally formed in 1997 as a joint venture between OSI Pharmaceuticals of Uniondale, New York, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, and Hoffman LaRoche of Basel, Switzerland.